Inventor · disambiguated record
Michael Bukrinsky
Also filed as: BUKRINSKY MICHAEL · BUKRINSKY MICHAEL L
6 granted patents·1 pending application·10 citations·filing 1996–2021
73Inventor score
Files withTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION3BUKRINSKY MICHAEL1PICOWER INST MED RES1UNIV CALIFORNIA1UNIV GEORGE WASHINGTON1
Top patents by PatentIndex Score
7 records- 0168US11561217B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2021·Granted Jan 24, 2023·0 cites·9 claims
- 0262US11131661B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 0359US10684274B2Compounds inhibiting Nef-calnexin interactionTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2017·Granted Jun 16, 2020·0 cites·1 claims
- 0454US6297253B1Compounds and methods of use to treat infectious diseasesPICOWER INST MED RES·Filed 1996·Granted Oct 2, 2001·10 cites·24 claims
- 0551US12227562B2Compositions and methods to treat viral infection and co-morbiditiesUNIV CALIFORNIA·Filed 2021·Granted Feb 18, 2025·0 cites·16 claims
- 0645US2009258024A1Compositions and methods for diagnosis and treatment of chronic inflammatory diseasesUNIV GEORGE WASHINGTON·Filed 2009·Application pending·0 cites
- 0737US8470526B2Method of suppressing human immunodeficiency virus (HIV) replication in a subject by administering a liver X receptor (LXR) agonistBUKRINSKY MICHAEL·Filed 2006·Granted Jun 25, 2013·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Michael Bukrinsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →